These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33931297)

  • 1. Novel agents for the treatment of lymphomas during pregnancy: A comprehensive literature review.
    Luttwak E; Gurevich-Shapiro A; Azem F; Lishner M; Klieger C; Herishanu Y; Perry C; Avivi I
    Blood Rev; 2021 Sep; 49():100831. PubMed ID: 33931297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatment of lymphoma in pregnancy.
    Gurevich-Shapiro A; Avivi I
    Expert Rev Hematol; 2019 Jun; 12(6):449-459. PubMed ID: 31055974
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hematologic neoplasms during pregnancy].
    Tartas NE; Foncuberta MC; Avalos JC
    Medicina (B Aires); 2007; 67(6 Pt 2):729-36. PubMed ID: 18422070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of hematologic malignancies during pregnancy].
    Maloisel F; Dreyfus M; Neuhart D; Ritter J; Oberling F
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(6):602-7. PubMed ID: 8964958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic therapy and pregnancy.
    Ebert U; Löffler H; Kirch W
    Pharmacol Ther; 1997; 74(2):207-20. PubMed ID: 9336023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiblastic treatment of haematological malignancies during pregnancy: a crucial decision.
    Michieli M; Peccatori FA; Lleshi A; Del Pup L; Valente D; Rupolo M; Tirelli U; Berretta M
    Int J Immunopathol Pharmacol; 2012; 25(2 Suppl):21S-32S. PubMed ID: 23092517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the management of hematologic malignancies in pregnancy.
    Lavi N; Horowitz NA; Brenner B
    Womens Health (Lond); 2014 May; 10(3):255-66. PubMed ID: 24956292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy during Pregnancy: Cases of Hodgkin's and Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia, Breast Cancer, Nasopharyngeal Cancer, and Choriocarcinoma.
    Beksac K; Orgul G; Ozyuncu O; Yurdakok M; Altundag K; Beksac MS
    Oncol Res Treat; 2017; 40(7-8):441-445. PubMed ID: 28700986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineoplastic drugs administered during pregnancy.
    Williams SF; Schilsky RL
    Semin Oncol; 2000 Dec; 27(6):618-22. PubMed ID: 11130468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis.
    Evens AM; Advani R; Press OW; Lossos IS; Vose JM; Hernandez-Ilizaliturri FJ; Robinson BK; Otis S; Nadav Dagan L; Abdallah R; Kroll-Desrosiers A; Yarber JL; Sandoval J; Foyil K; Parker LM; Gordon LI; Blum KA; Flowers CR; Leonard JP; Habermann TM; Bartlett NL
    J Clin Oncol; 2013 Nov; 31(32):4132-9. PubMed ID: 24043736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of haematological malignancy in pregnancy.
    El-Hemaidi I; Robinson SE
    Best Pract Res Clin Obstet Gynaecol; 2012 Feb; 26(1):149-60. PubMed ID: 22119057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple agent chemotherapy including bleomycin of non-Hodgkin's lymphoma during pregnancy.
    Ortega J
    Cancer; 1977 Dec; 40(6):2829-35. PubMed ID: 73411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of chronic myelogenous leukemia in pregnancy.
    Bhandari A; Rolen K; Shah BK
    Anticancer Res; 2015 Jan; 35(1):1-11. PubMed ID: 25550528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in pregnancy.
    Brewer M; Kueck A; Runowicz CD
    Clin Obstet Gynecol; 2011 Dec; 54(4):602-18. PubMed ID: 22031250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New active drugs in the treatment of lymphomas.
    Straneo M; Gianni L
    Curr Opin Oncol; 1994 Sep; 6(5):480-8. PubMed ID: 7827150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pregnancy and hematologic malignancies: a therapeutic approach].
    Delmer A; Bauduer F; Ajchenbaum-Cymbalista F; Rio B; Tafrechian S; Marie JP; Zittoun R
    Bull Cancer; 1994 Apr; 81(4):277-86. PubMed ID: 7703544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstetrical, fetal and postnatal effects of gestational antiblastic chemotherapy: how to counsel cancer patients.
    Del Pup L; Peccatori FA; Azim HA; Michieli M; Moioli M; Giorda G; Tirelli U; Berretta M
    Int J Immunopathol Pharmacol; 2012; 25(2 Suppl):33S-46S. PubMed ID: 23092518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports.
    Alizadeh H; Jaafar H; Kajtár B
    Ann Saudi Med; 2015; 35(6):468-71. PubMed ID: 26657232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Hematologic Malignancies: Special Considerations in Pregnant Women.
    Amit O; Barzilai M; Avivi I
    Drugs; 2015 Oct; 75(15):1725-38. PubMed ID: 26416583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant pregnancy and breast cancer: options for systemic therapy.
    Kelly HL; Collichio FA; Dees EC
    Breast Dis; 2005-2006; 23():95-101. PubMed ID: 16823172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.